You just read:

Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome

News provided by

Isis Pharmaceuticals, Inc.

Jul 06, 2015, 07:00 ET